Watchlist for January 29, 2008

10:00 -- Consumer Confidence

More Calendars: U.S. Earnings | Conf. Calls | Surprises | IPO | Economic

Potential swing trades:

See one of the recent 'Chart Reading' posts for some potential swing candidates.

Potential day trades:

Gapping Down

In reaction to weak earnings/guidance: VMW -27.7% (also downgraded to Average at Caris), ZRAN -20.2%, XPRT -18.7%, ICUI -15.7%, NHWK -12.6% (also downgraded to Equal Weight at Morgan Stanley), EMC -8.3%, RBI -6.8%, SII -6.5%, X -5.5%, AAI -5.3%, ALB -4.7% (also downgraded to Perform at Oppenheimer), EWBC -4.1%, USG -3.8%, CAH -2.9%, CLMS -2.9%, AXP -2.7%, CNW -2.7%, PCL -2.1%, MTH -1.5%... Other news: SEPR -5.3% (announced that it is conducting a review of its government price reporting), EXM -4.5% (announces plan to acquire QMAR), VTR -3.5% (announces a 3.9 mln share common stock offering)... Analyst downgrades: LEAP -4.5% (downgraded to Underperform at Wachovia), TGIC -3.9% (downgraded to Market Perform at Wachovia), DIS -3.8% (downgraded to Sell at Citigroup), NILE -2.9% (downgraded to Sell at Amtech), MOLX -2.8% (downgraded to Underperform at Credit Suisse), WABC -1.7% (downgraded to Hold at Stern Agee), LFC -1.3% (downgraded to Underperform at Bear Sterns), PMI -1.1% (downgraded to Market Perform at Wachovia).

Gapping Up

In reaction to strong earnings/guidance: ZMH +10.3%, LXK +9.1%, NNDS +8.6%, SSCC +8.4%, CXG +6.3%, ARM +6.2%, STLD +5.7%, VLO +4.9%, NSTC +4.9%, CX +4.2%, HW +4.0%, STLY +3.6%, ARG +3.4% (also increases dividend by 33%), IPAR +3.4%, AVY +3.2%, UNM +1.9%, DOW +1.8%, PLXT +1.3%... M&A news: QMAR +32.6% (to be acquired by Excel Maritime for ~$26.48/share)... Select drybulk shippers showing strength on news that EXM is buying QMAR: DSX +6.4%, EGLE +6.2%, TBSI +5.0%, DRYS +4.6%... Other news: LTON +12.1% (BroadWebAsia proposes to make significant investment in Linktone), LNY +5.1% (still checking), ABK +2.4% (JPMorgan files amended 13G disclosing increased 7.7% stake, up from prior stake of 5.4%)... Analyst upgrades: GERN +5.6% (upgraded to Buy at UBS), NOVL +4.8% (upgraded to Buy at Jefferies, upgraded to Outperform at Oppenheimer), VMED +3.7% (upgraded to Buy from Hold at Citigroup), ARQL +3.2% (upgraded to Buy at UBS), ADCT +3.0% (upgraded to Buy at UBS), TTWO +2.2% (upgraded to Equal Weight at Lehman), MEDX +2.2% (initiated with Buy at UBS), POT +1.8% (upgraded to Equal Weight at Morgan Stanley), GOOG +1.1% (initiated with Buy at Cannaccord).